From SQZ Biotech Adds $72M as Cell Therapy Investment Keeps Burning Hot:

SQZ

SQZ—

SQZ Biotechnologies squeezes cells to open their membrane, allowing a protein or other material to enter. Image courtesy of SQZ.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Sponsored · Webinar
Aug. 19 – Next-Generation Drug Discovery: Leveraging E3 Ligases for Targeted Protein Degradation
This new paradigm may well define a next dimension of precision medicine
Eurofins Discovery

Sponsored · Video
The Bay Area and Beyond: Biocom Talks Innovation and COVID
A Fireside Chat with Biocom President & CEO Joe Panetta
Biocom

Xconomy on Demand

We offer a number of ways to subscribe for free!